CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of CKD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
6125 records.
CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
---|---|---|---|---|---|---|
C03201 | BRD-A93683007 | mabuprofen | cyclooxygenase inhibitor | Details | ||
C03202 | BRD-A13116749 | mabuterol | ADRB2 | adrenergic receptor agonist | Details | |
C03203 | BRD-K94948151 | macelignan | antioxidant; antiinflammatory agent | Details | ||
C03204 | BRD-K48812570 | macitentan | EDNRA|EDNRB | endothelin receptor antagonist | Details | |
C03205 | BRD-K48905682 | madrasin | cell splicing inhibitor | Details | ||
C03206 | BRD-K30649484 | mafenide | CA12|CA14|CA2|CA4|CA6|CA9 | carbonic anhydrase inhibitor | Details | |
C03207 | BRD-K26168087 | magnolol | GABRA1|PPARG | PPAR receptor agonist | Details | |
C03208 | BRD-A01976766 | malathion | ACHE|BCHE | cholinesterase inhibitor | Details | |
C03209 | BRD-A18396475 | malic-acid | CS|ME2|PKD2L1 | Details | ||
C03210 | BRD-K97884852 | malotilate | protein synthesis stimulant | Details | ||
C03211 | BRD-K01624185 | maltobionic-acid | matrix metalloprotease inhibitor | Details | ||
C03212 | BRD-A91448670 | mandelic-acid | Details | |||
C03213 | BRD-K57365211 | mangafodipir | contrast agent | Details | ||
C03214 | BRD-A90695733 | manidipine | CACNA1C|CACNA1D | calcium channel blocker | Details | |
C03215 | BRD-K66035042 | mannitol-D | diuretic | Details | ||
C03216 | BRD-K25433859 | maprotiline | ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR2A|HTR2C|HTR7|SLC6A2 | norepinephrine reputake inhibitor; tricyclic antidepressant | Details | |
C03217 | BRD-A04352665 | maraviroc | CCR5 | CC chemokine receptor antagonist | Details | |
C03218 | BRD-K71926323 | marbofloxacin | bacterial DNA gyrase inhibitor | Details | ||
C03219 | BRD-K59524082 | maribavir | PYGM | cytomegalovirus inhibitor; protein kinase inhibitor | Details | |
C03220 | BRD-K21396683 | marimastat | MMP1|MMP10|MMP11|MMP12|MMP13|MMP14|MMP15|MMP16|MMP17|MMP19|MMP2|MMP20|MMP21|MMP23A|MMP24|MMP25|MMP26|MMP27|MMP28|MMP3|MMP7|MMP8|MMP9 | matrix metalloprotease inhibitor | Details | |
C03221 | BRD-K76594255 | maropitant | TACR1 | neurokinin receptor antagonist | Details | |
C03222 | BRD-K71035033 | masitinib | FGFR3|KIT|PDGFRA|PDGFRB | KIT inhibitor; PDGFR tyrosine kinase receptor inhibitor; src inhibitor | Details | |
C03223 | BRD-A87130939 | masoprocol | ALOX5 | lipoxygenase inhibitor | Details | |
C03224 | BRD-K25312248 | matrine | OPRK1 | opioid receptor agonist | Details | |
C03225 | BRD-K07790550 | mavoglurant | GRM5 | glutamate receptor antagonist | Details | |
C03226 | BRD-K81332461 | maxacalcitol | VDR | vitamin D receptor agonist | Details | |
C03227 | BRD-K15898725 | maytansinol-isobutyrate | Details | |||
C03228 | BRD-A68464583 | mazindol | SLC6A2|SLC6A3|SLC6A4 | dopamine reuptake inhibitor; selective serotonin reuptake inhibitor (SSRI) | Details | |
C03229 | BRD-K32218650 | MBX-2982 | GPR119 | glucose dependent insulinotropic receptor agonist | Details | |
C03230 | BRD-K50712474 | MC-1 | AADAT|ABAT|AGXT|AGXT2|ALAS1|AZIN2|BCAT1|BCAT2|CBS|CCBL1|CCBL2|CSAD|CTH|DDC|FTCD|GAD1|GAD2|GADL1|GCAT|GLDC|GOT1|GOT2|GPT|GPT2|HDC|IGSF10|KYNU|MOCOS|NFS1|OAT|ODC1|PDXDC1|PDXP|PHYKPL|PNPO|PROSC|PSAT1|PYGB|PYGL|PYGM|SCLY|SDS|SDSL|SEPSECS|SGPL1|SHMT1|SHMT2|SPTLC1|SPTLC2|SPTLC3|SRR|TAT|THNSL1 | Details | ||
C03231 | BRD-K55418700 | MCC950 | NLRP3 | NOD like receptor inhibitor | Details | |
C03232 | BRD-K31168993 | McN-5652-(+/-) | selective serotonin reuptake inhibitor (SSRI) | Details | ||
C03233 | BRD-K73276278 | MCOPPB | OPRL1 | nociceptin/orphanin FQ (NOP) receptor agonist | Details | |
C03234 | BRD-K75844781 | mCPP | HTR1A|HTR1D|HTR1E|HTR2A|HTR2B|HTR2C|HTR6 | serotonin receptor agonist | Details | |
C03235 | BRD-K24031866 | MC1568 | HDAC2 | HDAC inhibitor | Details | |
C03236 | BRD-K92758126 | MD-920 | AADACL2 | NFkB pathway inhibitor | Details | |
C03237 | BRD-K61128465 | mdivi-1 | DNM1 | dynamin inhibitor | Details | |
C03238 | BRD-A62057054 | MDL-11939 | HTR2A|HTR2B|HTR2C | serotonin receptor antagonist | Details | |
C03239 | BRD-K50888640 | MDL-27531 | glycine receptor agonist | Details | ||
C03240 | BRD-K59753853 | MDL-29951 | FBP1 | glutamate receptor antagonist | Details | |
C03241 | BRD-A17453586 | MDL-72832 | HTR1A | serotonin receptor agonist | Details | |
C03242 | BRD-A50764878 | MDL-73005EF | HTR1A | serotonin receptor antagonist | Details | |
C03243 | BRD-K70840370 | MDMS | DNA inhibitor | Details | ||
C03244 | BRD-K24283677 | ME-0328 | PARP3 | PPAR receptor antagonist | Details | |
C03245 | BRD-K77987382 | mebendazole | TUBA1A|TUBB|TUBB4B | tubulin polymerization inhibitor | Details | |
C03246 | BRD-A09467419 | mebeverine | CHRM1 | acetylcholine receptor antagonist | Details | |
C03247 | BRD-K29713308 | mebhydrolin | antihistamine | Details | ||
C03248 | BRD-K29713308 | mebhydroline-1,5-naphtalenedisulfonate | Details | |||
C03249 | BRD-K76606751 | mebicar | anxiolytic | Details | ||
C03250 | BRD-K96691275 | mebrofenin | Details | |||
C03251 | BRD-A20119038 | mecamylamine | CHRNA1|CHRNA2|CHRNA3|CHRNA4|CHRNA6|CHRNA7 | acetylcholine receptor antagonist | Details | |
C03252 | BRD-K28405228 | mecarbinate | Details | |||
C03253 | BRD-K12829205 | mechlorethamine | DNA inhibitor | Details | ||
C03254 | BRD-K25075681 | meclinertant | NTSR1|NTSR2 | neurotensin receptor antagonist | Details | |
C03255 | BRD-A50311610 | meclizine | HRH1|NR1I3 | constitutive androstane receptor (CAR) agonist | Details | |
C03256 | BRD-A07600638 | meclocycline-sulfosalicylate | bacterial 50S ribosomal subunit inhibitor | Details | ||
C03257 | BRD-K50398167 | meclofenamic-acid | ALOX5|CNR1|KCNQ2|KCNQ3|PTGS1|PTGS2 | cyclooxygenase inhibitor; prostanoid receptor antagonist | Details | |
C03258 | BRD-K10314788 | meclofenoxate | nootropic agent | Details | ||
C03259 | BRD-A77473570 | mecysteine | analgesic agent | Details | ||
C03260 | BRD-A21607826 | medetomidine | ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C | adrenergic receptor agonist | Details | |
C03261 | BRD-K92908289 | medica-16 | FFAR1 | ATP citrase lyase inhibitor | Details | |
C03262 | BRD-K40715924 | medorinone | Details | |||
C03263 | BRD-K94072573 | medronic-acid | bone resorption inhibitor | Details | ||
C03264 | BRD-K99615199 | medroxyprogesterone | ESR1|PGR | progesterone receptor agonist | Details | |
C03265 | BRD-A61221616 | medroxyprogesterone-acetate | progesterone receptor agonist | Details | ||
C03266 | BRD-A59014912 | medrysone | NR3C1 | glucocorticoid receptor agonist | Details | |
C03267 | BRD-K92778217 | mefenamic-acid | KCNQ1|PTGS1|PTGS2|TRPM3 | cyclooxygenase inhibitor | Details | |
C03268 | BRD-K20655524 | mefexamide | psychoactive drug | Details | ||
C03269 | BRD-A89585551 | mefloquine | ADORA2A|HBA1 | adenosine receptor antagonist; hemoglobin antagonist | Details | |
C03270 | BRD-K19507340 | megestrol-acetate | NR3C1|PGR | progesterone receptor agonist | Details | |
C03271 | BRD-K51324732 | meglitinide | CCR2 | potassium channel blocker | Details | |
C03272 | BRD-K28595280 | meglumine | excipient | Details | ||
C03273 | BRD-K00495673 | meglutol | HMGCR | HMGCR inhibitor | Details | |
C03274 | BRD-K14529030 | meisoindigo | STAT3 | STAT inhibitor | Details | |
C03275 | BRD-K12244279 | MEK1-2-inhibitor | MAP2K2 | MEK inhibitor | Details | |
C03276 | BRD-K82244583 | MEK162 | MAP2K1|MAP2K2 | MEK inhibitor | Details | |
C03277 | BRD-K97530723 | melatonin | ASMT|CALM1|CALR|EPX|ESR1|HTR2B|MPO|MTNR1A|MTNR1B|NQO2|RORB | melatonin receptor agonist; nitric oxide synthase inhibitor | Details | |
C03278 | BRD-K79392608 | meldonium | BBOX1 | gamma butyrobetaine hydroxylase inhibitor | Details | |
C03279 | BRD-A42746051 | melengestrol-acetate | progesterone receptor agonist | Details | ||
C03280 | BRD-A25827085 | melevodopa | DDC | dopamine precursor; dopamine receptor agonist | Details | |
C03281 | BRD-A84174393 | meloxicam | PTGS1|PTGS2 | cyclooxygenase inhibitor | Details | |
C03282 | BRD-K92984783 | melperone | DRD2|HTR2A | dopamine receptor antagonist; serotonin receptor antagonist | Details | |
C03283 | BRD-K87827419 | melphalan | DNA alkylating agent; DNA inhibitor | Details | ||
C03284 | BRD-K36394566 | melphalan-n-oxide | HIF1A | hypoxia inducible factor inhibitor | Details | |
C03285 | BRD-A07164067 | meluadrine | Details | |||
C03286 | BRD-A79803969 | memantine | CHRFAM7A|DRD2|GRIN1|GRIN2A|GRIN2B|GRIN3A|HTR3A | glutamate receptor antagonist | Details | |
C03287 | BRD-K78126613 | menadione | AOX1|BGLAP|F10|F2|F7|F9|GGCX|NQO1|NQO2|PROC|PROS1|PROZ|VKORC1|VKORC1L1 | mitochondrial DNA polymerase inhibitor; phosphatase inhibitor | Details | |
C03288 | BRD-A19777893 | menadione-bisulfite | GGCX|VKORC1|VKORC1L1 | vitamin K | Details | |
C03289 | BRD-K75864342 | menatetrenone | bone resorption inhibitor | Details | ||
C03290 | BRD-K53852914 | menbutone | Details | |||
C03291 | BRD-A45889380 | mepacrine | PLA2G1B|PLA2G4A|PLA2G6|PLCL1 | cytokine production inhibitor; NFkB pathway inhibitor; TP53 activator | Details | |
C03292 | BRD-A11662333 | meparfylon | Details | |||
C03293 | BRD-A82772293 | mepazine | MALT1 | MALT1 inhibitor (JH) | Details | |
C03294 | BRD-A62421304 | mepenzolate | CHRM1|CHRM3 | acetylcholine receptor antagonist | Details | |
C03295 | BRD-A55469827 | mephenesin | muscle relaxant | Details | ||
C03296 | BRD-K18194590 | mephentermine | ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3 | adrenergic receptor agonist | Details | |
C03297 | BRD-A83937277 | mephenytoin | SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A | hydantoin antiepileptic | Details | |
C03298 | BRD-K78299798 | mepiroxol | Details | |||
C03299 | BRD-A03216249 | mepivacaine | SCN10A | potassium channel blocker; sodium channel blocker | Details | |
C03300 | BRD-K18207669 | meprednisone | NR3C1 | Details |